Dashboard
Investment deals 
Investor briefings
Company alerts
Investment news
Investment videos
Stock trackerInvestment news
Project led by Thymmune Therapeutics aims to restore damaged or non-functional thymus tissue. The US Department of Health and Human Services, through the Advanced Research Projects Agency for Health (ARPA-H),…
Denmark’s Novo Nordisk Foundation has committed up to €127 million to establish a cutting-edge facility dedicated to advancing cell therapies for human testing. The new facility, called the Novo Nordisk…
Longevity.Technology’s CEO reports from Day 1 of the Longevity Investors Conference in Switzerland. Set in the exclusive resort of Gstaad in Switzerland, today saw the start of Longevity Investors Conference…
Neurodegenerative disease therapeutics company Vincere Biosciences has been awarded a research grant of $700,000 by the National Institute of Neurological Disorders and Stroke. The Phase I Small Business Innovation Research…
A team of researchers at the University of Alabama at Birmingham has been awarded a five-year, $3.2 million grant from the National Institute on Aging to investigate the effects of…
British gene therapy company Crucible Therapeutics, a spinout from the University of Sheffield, has emerged with £5 million ($6.1 million) in funding from Northern Gritstone and Argobio Studio. The company…
Digital digestive health company Vivante Health has concluded a $31 million Series B funding round to advance its gut health platform GIThrive. The digital platform provides virtual gastrointestinal care, linking…
Methuselah Foundation’s CEO David Gobel on clinging to the longevity biotech mast while waiting for the rising tide. September is whizzing by, and that means that it’s not long to…
Dr Alex Colville joins forces with Laura Deming to advance The Longevity Fund’s mission and lead investments in longevity science moonshots. San Francisco-based age1, a venture capital firm catalyzing the…
